RCKT Historical PE Ratio image   This RCKT PE ratio history page last updated 3/11/2024
RCKT PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/26/2024
29.79-0.64-2.94NA
Q3 2023
11/6/2023
19.93-0.75-3.22NA
Q2 2023
8/10/2023
16.78-0.82-3.34NA
Q1 2023
5/4/2023
18.69-0.73-3.35NA
Q4 2022
2/27/2023
18.46-0.92-3.29NA
Q3 2022
11/3/2022
17.78-0.87-3.06NA
Q2 2022
8/8/2022
15.84-0.83-2.98NA
Q1 2022
5/5/2022
10.00-0.67-2.70NA
Q4 2021
2/24/2022
17.79-0.69-2.68NA
Q3 2021
11/3/2021
34.69-0.79-3.07NA
Q2 2021
8/9/2021
33.63-0.55-2.81NA
Q1 2021
5/10/2021
43.35-0.65-2.71NA
Q4 2020
2/25/2021
51.86-1.08-2.51NA
Q3 2020
11/4/2020
31.50-0.53-1.82NA
Q2 2020
8/5/2020
25.26-0.45-1.67NA
Q1 2020
5/6/2020
17.13-0.45-1.60NA
Q4 2019
3/5/2020
19.10-0.39-1.58NA
Q3 2019
11/7/2019
15.16-0.38-1.85NA
Q2 2019
8/7/2019
12.07-0.38-1.87NA
Q1 2019
5/8/2019
18.96-0.43-1.89NA
Q4 2018
3/7/2019
14.55-0.66-1.88NA
Q3 2018
11/7/2018
18.44-0.40NANA
Q2 2018
8/8/2018
21.50-0.40NANA
Q1 2018
5/11/2018
17.97-0.42NANA
RCKT Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/26/2024
29.79-0.64-2.56NA
Q3 2023
11/6/2023
19.93-0.75-3.00NA
Q2 2023
8/10/2023
16.78-0.82-3.28NA
Q1 2023
5/4/2023
18.69-0.73-2.92NA
Q4 2022
2/27/2023
18.46-0.92-3.68NA
Q3 2022
11/3/2022
17.78-0.87-3.48NA
Q2 2022
8/8/2022
15.84-0.83-3.32NA
Q1 2022
5/5/2022
10.00-0.67-2.68NA
Q4 2021
2/24/2022
17.79-0.69-2.76NA
Q3 2021
11/3/2021
34.69-0.79-3.16NA
Q2 2021
8/9/2021
33.63-0.55-2.20NA
Q1 2021
5/10/2021
43.35-0.65-2.60NA
Q4 2020
2/25/2021
51.86-1.08-4.32NA
Q3 2020
11/4/2020
31.50-0.53-2.12NA
Q2 2020
8/5/2020
25.26-0.45-1.80NA
Q1 2020
5/6/2020
17.13-0.45-1.80NA
Q4 2019
3/5/2020
19.10-0.39-1.56NA
Q3 2019
11/7/2019
15.16-0.38-1.52NA
Q2 2019
8/7/2019
12.07-0.38-1.52NA
Q1 2019
5/8/2019
18.96-0.43-1.72NA
Q4 2018
3/7/2019
14.55-0.66-2.64NA
Q3 2018
11/7/2018
18.44-0.40-1.60NA
Q2 2018
8/8/2018
21.50-0.40-1.60NA
Q1 2018
5/11/2018
17.97-0.42-1.68NA
Quotes delayed 20 minutes

Email EnvelopeFree RCKT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Rocket Pharmaceuticals (RCKT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RCUS PE Ratio History
RDNT PE Ratio History
REGN PE Ratio History
REPH PE Ratio History
REPL PE Ratio History
RETA PE Ratio History
RGEN PE Ratio History
RGLS PE Ratio History
RGNX PE Ratio History
RIGL PE Ratio History
On this page we presented the RCKT PE Ratio History information for Rocket Pharmaceuticals' stock. The average RCKT PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RCKT PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RCKT PE ratio history result, against the recent PE: when this page was posted on 3/8/2024, the most recent closing price for RCKT had been 27.87, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on RCKT or any other given stock, valuation analysis for RCKT can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Rocket Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for RCKT. Thanks for visiting, and the next time you need to research RCKT PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: FSBW market cap history, RIGL Insider Buying, MAM Historical Stock Prices.

 

RCKT PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.